| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
51,320,000 |
| Market
Cap: |
5.00(B) |
| Last
Volume: |
262,995 |
Avg
Vol: |
492,576 |
| 52
Week Range: |
$71.24 - $95.38 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P SMALLCAP 600 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 438 |
| Guru Rank Value : 3.1 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Haemonetics is a global healthcare company providing a suite of medical products and solutions for customers. Co.'s technology addresses medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Co. has three principal reporting segments: Plasma, which provides automated plasma collection and donor management software systems; Blood Center, which provides a range of solutions that improve donor collection centers' ability to collect and filter blood and separate blood components; and Hospital, which has four product lines, including Hemostasis Management, Vascular Closure, Transfusion Management and Cell Salvage.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
2,305 |
2,305 |
24,823 |
94,111 |
| Total Sell Value |
$218,975 |
$218,975 |
$2,201,702 |
$7,357,280 |
| Total People Sold |
1 |
1 |
4 |
9 |
| Total Sell Transactions |
1 |
1 |
7 |
34 |
| End Date |
2024-02-15 |
2023-11-14 |
2023-05-16 |
2022-05-16 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Burke Willaim P |
EVP, Chief Financial Officer |
• • – |
2019-10-04 |
4 |
A |
$0.00 |
$0 |
D/D |
41,654 |
54,668 |
|
- |
|
| Basil Michelle L |
EVP and General Counsel |
• • – |
2019-10-04 |
4 |
A |
$0.00 |
$0 |
D/D |
19,516 |
32,654 |
|
- |
|
| Scanlan Jacqueline |
SVP, Global Human Resources |
• • – |
2019-10-04 |
4 |
A |
$0.00 |
$0 |
D/D |
5,204 |
9,899 |
|
- |
|
| Burke Willaim P |
EVP, Chief Financial Officer |
• • – |
2019-10-01 |
4 |
AS |
$124.47 |
$901,198 |
D/D |
(7,164) |
13,014 |
|
- |
|
| Burke Willaim P |
EVP, Chief Financial Officer |
• • – |
2019-10-01 |
4 |
OE |
$41.64 |
$238,098 |
D/D |
5,718 |
20,178 |
|
- |
|
| Scanlan Jacqueline |
SVP, Global Human Resources |
• • – |
2019-09-09 |
4 |
AS |
$127.44 |
$195,111 |
D/D |
(1,531) |
4,695 |
|
- |
|
| Scanlan Jacqueline |
SVP, Global Human Resources |
• • – |
2019-09-09 |
4 |
OE |
$93.52 |
$122,324 |
D/D |
1,308 |
6,226 |
|
- |
|
| Llorens Josep |
SVP, Global Manufacturing |
• • – |
2019-09-05 |
4 |
S |
$129.94 |
$13,124 |
D/D |
(101) |
2,770 |
|
- |
|
| Bolorforosh Said |
EVP, Chief Technology Officer |
• • – |
2019-08-30 |
4 |
S |
$133.73 |
$87,861 |
D/D |
(657) |
2,316 |
|
- |
|
| Bolorforosh Said |
EVP, Chief Technology Officer |
• • – |
2019-08-30 |
4 |
OE |
$93.52 |
$77,809 |
D/D |
832 |
2,973 |
|
- |
|
| Simon Christopher |
President & CEO |
• • – |
2019-08-19 |
4 |
S |
$137.43 |
$6,990,927 |
D/D |
(50,869) |
304,572 |
|
- |
|
| Simon Christopher |
President & CEO |
• • – |
2019-08-14 |
4 |
A |
$0.00 |
$0 |
D/D |
114,298 |
355,441 |
|
- |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2019-08-09 |
4 |
S |
$133.23 |
$63,284 |
D/D |
(475) |
2,789 |
|
- |
|
| Goldstein Dan |
VP, Corporate Controller |
• • – |
2019-08-09 |
4 |
OE |
$93.52 |
$44,422 |
D/D |
475 |
3,264 |
|
- |
|
| Gelbman Ronald G |
Director |
• • – |
2019-08-08 |
4 |
S |
$134.15 |
$227,518 |
D/D |
(1,696) |
48,384 |
|
- |
|
| Abernathy Robert E |
Director |
• • – |
2019-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,460 |
6,065 |
|
- |
|
| Gelbman Ronald G |
Director |
• • – |
2019-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,460 |
50,080 |
|
- |
|
| Dockendorff Charles J |
Director |
• • – |
2019-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,460 |
20,340 |
|
- |
|
| Burzik Catherine M |
Director |
• • – |
2019-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,460 |
11,755 |
|
- |
|
| Pomeroy Claire |
Director |
• • – |
2019-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,460 |
1,956 |
|
- |
|
| Kroll Mark W |
Director |
• • – |
2019-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,460 |
23,617 |
|
- |
|
| Meelia Richard J |
Director |
• • – |
2019-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,460 |
30,067 |
|
- |
|
| Zane Ellen M |
Director |
• • – |
2019-07-24 |
4 |
A |
$0.00 |
$0 |
D/D |
1,460 |
4,457 |
|
- |
|
| Simon Christopher |
President & CEO |
• • – |
2019-07-01 |
4 |
S |
$121.79 |
$609,924 |
D/D |
(5,008) |
241,143 |
|
- |
|
| Scanlan Jacqueline |
SVP, Global Human Resources |
• – – |
2019-06-17 |
4 |
AS |
$112.49 |
$410,139 |
D/D |
(3,646) |
4,918 |
|
- |
|
1312 Records found
|
|
Page 11 of 53 |
|
|
1.16 (1.21%) 
